vs
Aurinia Pharmaceuticals Inc.（AUPH）与Repay Holdings Corp（RPAY）财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是Aurinia Pharmaceuticals Inc.的1.0倍（$78.6M vs $77.1M），Aurinia Pharmaceuticals Inc.净利率更高（273.4% vs -178.3%，领先451.6%），Aurinia Pharmaceuticals Inc.同比增速更快（28.8% vs 0.4%），过去两年Aurinia Pharmaceuticals Inc.的营收复合增速更高（23.8% vs -1.3%）
Aurinia Pharmaceuticals是一家生物制药企业，专注于自身免疫疾病及肾脏疾病靶向疗法的研发与商业化，核心获批产品为用于治疗成人活动性狼疮性肾炎的Lupkynis，主要市场覆盖北美及欧洲地区。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商，为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案，涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具，助力客户简化交易流程、提升运营效率。
AUPH vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.0倍
$77.1M
营收增速更快
AUPH
高出28.4%
0.4%
净利率更高
AUPH
高出451.6%
-178.3%
两年增速更快
AUPH
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $77.1M | $78.6M |
| 净利润 | $210.8M | $-140.1M |
| 毛利率 | 88.6% | 74.2% |
| 营业利润率 | 43.1% | -182.2% |
| 净利率 | 273.4% | -178.3% |
| 营收同比 | 28.8% | 0.4% |
| 净利润同比 | 14651.2% | -3304.1% |
| 每股收益（稀释后） | $1.52 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AUPHRPAY
| Q4 25 | $77.1M | $78.6M | ||
| Q3 25 | $73.5M | $77.7M | ||
| Q2 25 | $70.0M | $75.6M | ||
| Q1 25 | $62.5M | $77.3M | ||
| Q4 24 | $59.9M | $78.3M | ||
| Q3 24 | $67.8M | $79.1M | ||
| Q2 24 | $57.2M | $74.9M | ||
| Q1 24 | $50.3M | $80.7M |
净利润AUPHRPAY
| Q4 25 | $210.8M | $-140.1M | ||
| Q3 25 | $31.6M | $-6.4M | ||
| Q2 25 | $21.5M | $-102.3M | ||
| Q1 25 | $23.3M | $-7.9M | ||
| Q4 24 | $1.4M | $-4.1M | ||
| Q3 24 | $14.3M | $3.2M | ||
| Q2 24 | $722.0K | $-4.1M | ||
| Q1 24 | $-10.7M | $-5.2M |
毛利率AUPHRPAY
| Q4 25 | 88.6% | 74.2% | ||
| Q3 25 | 88.9% | 74.4% | ||
| Q2 25 | 89.8% | 75.7% | ||
| Q1 25 | 86.3% | 75.9% | ||
| Q4 24 | 90.7% | 76.3% | ||
| Q3 24 | 91.1% | 77.8% | ||
| Q2 24 | 84.4% | 78.2% | ||
| Q1 24 | 84.6% | 76.2% |
营业利润率AUPHRPAY
| Q4 25 | 43.1% | -182.2% | ||
| Q3 25 | 40.5% | -3.9% | ||
| Q2 25 | 28.7% | -138.7% | ||
| Q1 25 | 35.0% | -4.7% | ||
| Q4 24 | -2.8% | -1.5% | ||
| Q3 24 | 17.3% | -0.9% | ||
| Q2 24 | -2.6% | -4.6% | ||
| Q1 24 | -26.3% | -3.1% |
净利率AUPHRPAY
| Q4 25 | 273.4% | -178.3% | ||
| Q3 25 | 42.9% | -8.3% | ||
| Q2 25 | 30.7% | -135.2% | ||
| Q1 25 | 37.4% | -10.3% | ||
| Q4 24 | 2.4% | -5.3% | ||
| Q3 24 | 21.2% | 4.1% | ||
| Q2 24 | 1.3% | -5.4% | ||
| Q1 24 | -21.4% | -6.5% |
每股收益（稀释后）AUPHRPAY
| Q4 25 | $1.52 | $-1.68 | ||
| Q3 25 | $0.23 | $-0.08 | ||
| Q2 25 | $0.16 | $-1.15 | ||
| Q1 25 | $0.16 | $-0.09 | ||
| Q4 24 | $0.00 | $-0.04 | ||
| Q3 24 | $0.10 | $0.03 | ||
| Q2 24 | $0.01 | $-0.04 | ||
| Q1 24 | $-0.07 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.2M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $581.3M | $484.4M |
| 总资产 | $751.6M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势，按日历期对齐
现金及短期投资AUPHRPAY
| Q4 25 | $80.2M | $115.7M | ||
| Q3 25 | $72.9M | $95.7M | ||
| Q2 25 | $52.9M | $162.6M | ||
| Q1 25 | $66.1M | $165.5M | ||
| Q4 24 | $83.4M | $189.5M | ||
| Q3 24 | $36.6M | $168.7M | ||
| Q2 24 | $33.3M | $147.1M | ||
| Q1 24 | $63.9M | $128.3M |
总债务AUPHRPAY
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
股东权益AUPHRPAY
| Q4 25 | $581.3M | $484.4M | ||
| Q3 25 | $365.8M | $616.9M | ||
| Q2 25 | $335.3M | $633.7M | ||
| Q1 25 | $350.2M | $755.7M | ||
| Q4 24 | $377.5M | $761.3M | ||
| Q3 24 | $388.0M | $754.7M | ||
| Q2 24 | $364.6M | $815.4M | ||
| Q1 24 | $359.5M | $813.8M |
总资产AUPHRPAY
| Q4 25 | $751.6M | $1.2B | ||
| Q3 25 | $527.5M | $1.3B | ||
| Q2 25 | $502.6M | $1.4B | ||
| Q1 25 | $504.9M | $1.5B | ||
| Q4 24 | $550.6M | $1.6B | ||
| Q3 24 | $549.4M | $1.6B | ||
| Q2 24 | $523.5M | $1.5B | ||
| Q1 24 | $516.6M | $1.5B |
负债/权益比AUPHRPAY
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.7M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | — | $23.2M |
| 自由现金流率自由现金流/营收 | — | 29.6% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | 0.22× | — |
| 过去12个月自由现金流最近4个季度 | — | $90.7M |
8季度趋势，按日历期对齐
经营现金流AUPHRPAY
| Q4 25 | $45.7M | $23.3M | ||
| Q3 25 | $44.4M | $32.2M | ||
| Q2 25 | $44.2M | $33.1M | ||
| Q1 25 | $1.3M | $2.5M | ||
| Q4 24 | $30.1M | $34.3M | ||
| Q3 24 | $17.0M | $60.1M | ||
| Q2 24 | $15.8M | $31.0M | ||
| Q1 24 | $-18.6M | $24.8M |
自由现金流AUPHRPAY
| Q4 25 | — | $23.2M | ||
| Q3 25 | — | $32.1M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | — | $34.0M | ||
| Q3 24 | — | $59.8M | ||
| Q2 24 | — | $30.5M | ||
| Q1 24 | — | $24.7M |
自由现金流率AUPHRPAY
| Q4 25 | — | 29.6% | ||
| Q3 25 | — | 41.3% | ||
| Q2 25 | — | 43.6% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 30.6% |
资本支出强度AUPHRPAY
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 0.1% |
现金转化率AUPHRPAY
| Q4 25 | 0.22× | — | ||
| Q3 25 | 1.41× | — | ||
| Q2 25 | 2.06× | — | ||
| Q1 25 | 0.06× | — | ||
| Q4 24 | 21.07× | — | ||
| Q3 24 | 1.19× | 18.52× | ||
| Q2 24 | 21.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AUPH
| Products | $74.2M | 96% |
| License Collaboration And Royalty Revenue | $2.9M | 4% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
